These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 21736678)
21. Prevalence of exercise pulmonary arterial hypertension in scleroderma. Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147 [TBL] [Abstract][Full Text] [Related]
22. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Wigley FM; Lima JA; Mayes M; McLain D; Chapin JL; Ward-Able C Arthritis Rheum; 2005 Jul; 52(7):2125-32. PubMed ID: 15986394 [TBL] [Abstract][Full Text] [Related]
24. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand. Foocharoen C; Nanagara R; Kiatchoosakun S; Suwannaroj S; Mahakkanukrauh A Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025 [TBL] [Abstract][Full Text] [Related]
25. Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension. Wipff J; Kahan A; Hachulla E; Sibilia J; Cabane J; Meyer O; Mouthon L; Guillevin L; Junien C; Boileau C; Allanore Y Rheumatology (Oxford); 2007 Apr; 46(4):622-5. PubMed ID: 17166870 [TBL] [Abstract][Full Text] [Related]
26. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M; Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881 [TBL] [Abstract][Full Text] [Related]
27. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension. Marasini B; Cossutta R; Selmi C; Pozzi MR; Gardinali M; Massarotti M; Erario M; Battaglioli L; Biondi ML Clin Dev Immunol; 2005 Dec; 12(4):275-9. PubMed ID: 16584113 [TBL] [Abstract][Full Text] [Related]
28. Determinants of morbidity and mortality of systemic sclerosis in Canada. Al-Dhaher FF; Pope JE; Ouimet JM Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680 [TBL] [Abstract][Full Text] [Related]
29. Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. Hachulla E; Launay D; Yaici A; Berezne A; de Groote P; Sitbon O; Mouthon L; Guillevin L; Hatron PY; Simonneau G; Clerson P; Humbert M; Rheumatology (Oxford); 2010 May; 49(5):940-4. PubMed ID: 20144930 [TBL] [Abstract][Full Text] [Related]
30. Role of PDGF in fibrotic diseases and systemic sclerosis. Trojanowska M Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v2-4. PubMed ID: 18784131 [TBL] [Abstract][Full Text] [Related]
31. Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated? Nikpour M; Stevens W; Proudman SM; Buchbinder R; Prior D; Zochling J; Williams T; Gabbay E; Nandurkar H Intern Med J; 2013 May; 43(5):599-603. PubMed ID: 23668273 [TBL] [Abstract][Full Text] [Related]
32. Systemic sclerosis: an update. Varga J Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632 [TBL] [Abstract][Full Text] [Related]
35. HIV-associated pulmonary arterial hypertension: a clinical problem that is here to stay? Murphy D; Girgis RE Int J Clin Pract Suppl; 2009 Mar; (161):19-21. PubMed ID: 19178602 [TBL] [Abstract][Full Text] [Related]
36. Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis. Kubo M; Ihn H; Yamane K; Tamaki K J Rheumatol; 2002 Dec; 29(12):2558-64. PubMed ID: 12465152 [TBL] [Abstract][Full Text] [Related]
37. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505 [TBL] [Abstract][Full Text] [Related]